Trials
Search / Trial NCT05646602

Focused Shock Wave Therapy Outcomes in Peyronie's Disease and Erectile Dysfunction

Launched by MAYO CLINIC · Dec 2, 2022

Trial Information

Current as of January 16, 2025

Withdrawn

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Peyronie's Disease (PD) at any stage
  • The presence of penile plaque or pain at erection or curvature
  • PD therapy with or without simultaneous intralesional Xiaflex injection.
  • Exclusion Criteria:
  • Prior penile surgery or LiSWT.
  • Erective Dysfunction (ED) not responding to phosphodiesterase-type five inhibitors or intracavernosal injections.
  • Unwillingness or inability to provide informed consent.
  • Having active or life-threatening coagulopathies ore using anti-coagulation /anti-platelet medications

Trial Officials

Tobias Kohler, MD, MPH

Principal Investigator

Mayo Clinic

About Mayo Clinic

Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.

Locations

Rochester, Minnesota, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials